Breast Cancer Therapeutics Market
Breast Cancer Therapeutics Market Forecasts to 2030 - Global Analysis By Type (Hormonal Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Therapies), Cancer Type, Distribution Channel, End User and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $29.1 BN |
|
Projected Year Value (2030) |
US $54.3 BN |
|
CAGR (2023 - 2030) |
9.3% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Breast Cancer Therapeutics Market is accounted for $29.1 billion in 2023 and is expected to reach $54.3 billion by 2030 growing at a CAGR of 9.3% during the forecast period. Breast cancer therapeutics refers to the various treatments and interventions designed to manage, treat, or cure breast cancer. These therapeutics encompass a wide range of approaches, including surgery, chemotherapy, radiation therapy, targeted therapy, hormone therapy, immunotherapy, and newer emerging treatments like precision medicine and gene therapy. Therapeutic approaches often vary based on the stage of the cancer, its specific characteristics, and the individual patient's health and preferences.
According to the Breast Cancer Organizations statistics, as of January 2022, breast cancer affects more than 3.8 million American women. The statistics indicate that in the year 2022, around 30% of newly diagnosed cancers among women are estimated to be breast cancer cases.
Market Dynamics:
Driver:
Rising incidence of breast cancer
The increasing prevalence of breast cancer globally prompts greater demand for therapeutic options, spurring research and development efforts. Emerging technologies offer more targeted therapies, improving efficacy and reducing side effects. The growing awareness of early detection emphasizes the need for comprehensive treatment solutions, creating a conducive environment for market expansion. This surge in demand encourages competitive pricing strategies and fosters collaborations for enhanced patient care, propelling the market forward.
Restraint:
Adverse effects of therapeutics
Adverse reactions arising from breast cancer therapeutics, such as targeted therapies, may limit the market growth. In cases of severe adverse reactions, the patient may not be able to use that particular drug and may have to move toward other types of therapeutics. Side effects of treatments can be severe and impact the patient's quality of life.
Opportunity:
Expanding geriatric population
With an aging population worldwide, there's a higher incidence of cancer, including breast cancer, leading to a greater demand for therapeutic options. With advanced age being a primary risk factor for breast cancer, the growing demographic of older individuals creates a larger pool of potential patients. Additionally, increased awareness and improved screening methods within this population offer opportunities for early detection and intervention, fostering better treatment outcomes and market expansion.
Threat:
High cost of therapies
Many advanced breast cancer treatments are expensive, limiting access for patients without adequate insurance coverage or financial resources. Affordability issues lead to unequal access to innovative medications, impacting treatment efficacy and patient outcomes. High expenses also burden healthcare systems, constraining resources and potentially limiting research and development of newer, more accessible therapies. These cost barriers hinder the growth of the market.
Covid-19 Impact:
The coronavirus outbreak has disrupted the global economy, inflicting economic burden and financial adversities. Many sectors have witnessed drastic transition including the healthcare sector. Hospital admissions regarding COVID-19 affected patients were prioritized, with other medical procedures postponed. The pandemic has had a limited impact on this global market as this treatment is considered a life-saving treatment for several patients.
The targeted therapy segment is expected to be the largest during the forecast period
The targeted therapy segment is expected to be the largest during the forecast period. Targeted therapy in breast cancer offers precise treatment, attacking specific molecules crucial for cancer growth while sparing healthy cells. It enhances efficacy with reduced side effects compared to traditional treatments, improving patient outcomes. Their ability to prevent cancer's progression by pinpointing distinct pathways amplifies treatment effectiveness, promising better survival rates and a higher quality of life for patients.
The hospital pharmacies segment is expected to have the highest CAGR during the forecast period
The hospital pharmacies segment is expected to have the highest CAGR during the forecast period. Hospital pharmacies play a pivotal role in breast cancer therapeutics by ensuring timely access to specialized medications, optimizing drug regimens, and providing personalized care. They facilitate seamless coordination between healthcare teams, ensuring accurate dosing and monitoring of treatments, thereby enhancing patient outcomes.
Region with largest share:
North America is projected to hold the largest market share during the forecast period due to government initiatives, and the presence of key pharmaceutical companies. The region is dynamic, with ongoing research, clinical trials, and collaborations between pharmaceutical companies and research institutions driving innovation. It's also supported by strong healthcare infrastructure and favorable reimbursement policies, allowing patients access to advanced treatments.
Region with highest CAGR:
Asia Pacific is projected to hold the highest CAGR over the forecast period due to various factors, including increasing awareness, advancements in technology and improved access to healthcare facilities. There's also a growing trend toward personalized medicine, where treatments are tailored based on the specific characteristics of the tumor. The adoption of advanced diagnostic tools and treatment modalities has significantly improved patient outcomes.
Key players in the market
Some of the key players in Breast Cancer Therapeutics market include Exelixis Inc., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Merck and Co. Inc., Sanofi, Teva Pharmaceutical Industries Ltd., Viatris Inc., Novartis AG, Perkin Elmer Inc., Pfizer Inc., Puma Biotechnology Inc., NanoString Technologies Inc., Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Eli Lilly and Co., AbbVie Inc., Amgen Inc., Bristol Myers Squibb and Clovis Oncology.
Key Developments:
In February 2023, Gilead Sciences, Inc. received the U.S. Food and Drug Administration (FDA) approval for Trodelvy to treat adult patients with inoperable locally advanced or metastatic breast cancer. This approval anticipates enhancing the available treatment choices and likely leading to improved outcomes for patients suffering from breast cancer.
In November 2022, Eli Lilly and Company launched the additional indication for Ramiven (abemaciclib), following approval from the Drugs Controller General of India (DCGI), in combination with endocrine therapy for adjuvant treatment in adult patients with Hormone Receptor (HR)-positive, HER2 negative, node-positive EBC at high risk of recurrence.
Therapies Covered:
• Hormonal Therapy
• Targeted Therapy
• Chemotherapy
• Immunotherapy
• Other Therapies
Cancer Types Covered:
• HER2+
• Hormone Receptor
Distribution Channels Covered:
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
End Users Covered:
• Research Institutions
• Diagnostic Centers
• Clinics
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Breast Cancer Therapeutics Market, By Therapy
5.1 Introduction
5.2 Hormonal Therapy
5.2.1 Aromatase Inhibitors
5.2.2 Estrogen Receptor Downregulators (ERDs)
5.2.3 Selective Estrogen Receptor Modulators (SERMs)
5.3 Targeted Therapy
5.3.1 Trastuzumab
5.3.2 Pertuzumab
5.3.3 Everolimus
5.3.4 Ado-Trastuzumab Emtansine
5.3.5 Palbociclib
5.3.6 Ribociclib
5.3.7 Olaparib
5.3.8 Abemaciclib
5.4 Chemotherapy
5.5 Immunotherapy
5.6 Other Therapies
6 Global Breast Cancer Therapeutics Market, By Cancer Type
6.1 Introduction
6.2 HER2+
6.3 Hormone Receptor
7 Global Breast Cancer Therapeutics Market, By Distribution Channel
7.1 Introduction
7.2 Retail Pharmacies
7.3 Hospital Pharmacies
7.4 Online Pharmacies
8 Global Breast Cancer Therapeutics Market, By End User
8.1 Introduction
8.2 Research Institutions
8.3 Diagnostic Centers
8.4 Clinics
8.5 Other End Users
9 Global Breast Cancer Therapeutics Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Exelixis Inc.
11.2 F. Hoffmann La Roche Ltd.
11.3 GlaxoSmithKline Plc
11.4 Merck and Co. Inc.
11.5 Sanofi
11.6 Teva Pharmaceutical Industries Ltd.
11.7 Viatris Inc.
11.8 Novartis AG
11.9 Perkin Elmer Inc.
11.10 Pfizer Inc.
11.11 Puma Biotechnology Inc.
11.12 NanoString Technologies Inc.
11.13 Daiichi Sankyo Co. Ltd.
11.14 Eisai Co. Ltd.
11.15 Eli Lilly and Co.
11.16 AbbVie Inc.
11.17 Amgen Inc.
11.18 Bristol Myers Squibb
11.19 Clovis Oncology
List of Tables
1 Global Breast Cancer Therapeutics Market Outlook, By Region (2021-2030) ($MN)
2 Global Breast Cancer Therapeutics Market Outlook, By Therapy (2021-2030) ($MN)
3 Global Breast Cancer Therapeutics Market Outlook, By Hormonal Therapy
(2021-2030) ($MN)
4 Global Breast Cancer Therapeutics Market Outlook, By Aromatase Inhibitors (2021-2030) ($MN)
5 Global Breast Cancer Therapeutics Market Outlook, By Estrogen Receptor Downregulators (ERDs) (2021-2030) ($MN)
6 Global Breast Cancer Therapeutics Market Outlook, By Selective Estrogen Receptor Modulators (SERMs) (2021-2030) ($MN)
7 Global Breast Cancer Therapeutics Market Outlook, By Targeted Therapy (2021-2030) ($MN)
8 Global Breast Cancer Therapeutics Market Outlook, By Trastuzumab (2021-2030) ($MN)
9 Global Breast Cancer Therapeutics Market Outlook, By Pertuzumab (2021-2030) ($MN)
10 Global Breast Cancer Therapeutics Market Outlook, By Everolimus (2021-2030) ($MN)
11 Global Breast Cancer Therapeutics Market Outlook, By Ado-Trastuzumab Emtansine (2021-2030) ($MN)
12 Global Breast Cancer Therapeutics Market Outlook, By Palbociclib (2021-2030) ($MN)
13 Global Breast Cancer Therapeutics Market Outlook, By Ribociclib (2021-2030) ($MN)
14 Global Breast Cancer Therapeutics Market Outlook, By Olaparib (2021-2030) ($MN)
15 Global Breast Cancer Therapeutics Market Outlook, By Abemaciclib (2021-2030) ($MN)
16 Global Breast Cancer Therapeutics Market Outlook, By Chemotherapy (2021-2030) ($MN)
17 Global Breast Cancer Therapeutics Market Outlook, By Immunotherapy (2021-2030) ($MN)
18 Global Breast Cancer Therapeutics Market Outlook, By Other Therapies (2021-2030) ($MN)
19 Global Breast Cancer Therapeutics Market Outlook, By Cancer Type (2021-2030) ($MN)
20 Global Breast Cancer Therapeutics Market Outlook, By HER2+ (2021-2030) ($MN)
21 Global Breast Cancer Therapeutics Market Outlook, By Hormone Receptor (2021-2030) ($MN)
22 Global Breast Cancer Therapeutics Market Outlook, By Distribution Channel (2021-2030) ($MN)
23 Global Breast Cancer Therapeutics Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
24 Global Breast Cancer Therapeutics Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
25 Global Breast Cancer Therapeutics Market Outlook, By Online Pharmacies (2021-2030) ($MN)
26 Global Breast Cancer Therapeutics Market Outlook, By End User (2021-2030) ($MN)
27 Global Breast Cancer Therapeutics Market Outlook, By Research Institutions (2021-2030) ($MN)
28 Global Breast Cancer Therapeutics Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
29 Global Breast Cancer Therapeutics Market Outlook, By Clinics (2021-2030) ($MN)
30 Global Breast Cancer Therapeutics Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
